#METABOLOMICS WORKBENCH yuehaitao_20250317_203500 DATATRACK_ID:5734 STUDY_ID:ST003811 ANALYSIS_ID:AN006266 PROJECT_ID:PR002384 VERSION 1 CREATED_ON March 25, 2025, 1:38 pm #PROJECT PR:PROJECT_TITLE Characterisation of the gut microbiome in hypertensive and type II diabetic PR:PROJECT_TITLE populations in different regions of Xinjiang PR:PROJECT_SUMMARY In this study, the diversity of gut microbial profiles and their associations PR:PROJECT_SUMMARY with dietary habits and metabolites in different ethnic groups and disease PR:PROJECT_SUMMARY states were revealed through gut microbiome and metabolomic analyses of 192 PR:PROJECT_SUMMARY healthy and diseased people (including hypertension, type II diabetes and their PR:PROJECT_SUMMARY co-morbidities) in Xinjiang.It was found that the dominant genus in the Hui PR:PROJECT_SUMMARY group was Faecalibacterium, while the Uyghur group was dominated by Prevotella, PR:PROJECT_SUMMARY which is different from the previously reported distribution of enterotypes. PR:INSTITUTE Xinjiang University PR:LABORATORY Laboratory of Synthetic Biology, Xinjiang University PR:LAST_NAME Yue PR:FIRST_NAME Haitao PR:ADDRESS Yushugou Street, Shuimogou District, Urumqi City, Xinjiang Province PR:EMAIL yuehaitao@tsinghua.org.cn PR:PHONE 13639932226 #STUDY ST:STUDY_TITLE Characterisation of the gut microbiome in hypertensive and type II diabetic ST:STUDY_TITLE populations in different regions of Xinjiang ST:STUDY_SUMMARY In this study, the diversity of gut microbial profiles and their associations ST:STUDY_SUMMARY with dietary habits and metabolites in different ethnic groups and disease ST:STUDY_SUMMARY states were revealed through gut microbiome and metabolomic analyses of 192 ST:STUDY_SUMMARY healthy and diseased people (including hypertension, type II diabetes and their ST:STUDY_SUMMARY co-morbidities) in Xinjiang.It was found that the dominant genus in the Hui ST:STUDY_SUMMARY group was Faecalibacterium, while the Uyghur group was dominated by Prevotella, ST:STUDY_SUMMARY which is different from the previously reported distribution of enterotypes.The ST:STUDY_SUMMARY abundance of Prevotella was significantly higher in hypertensive patients and ST:STUDY_SUMMARY positively correlated with a high-salt diet, and the abundance of ST:STUDY_SUMMARY Bifidobacterium adolescentis was significantly higher in patients with type II ST:STUDY_SUMMARY diabetes.By integrative analysis of multi-omics data, we further found that ST:STUDY_SUMMARY changes in the proportion of specific microorganisms (e.g. ST:STUDY_SUMMARY Coriobacteriales_bacterium and Dorea_formicigenerans) in disease-comorbid states ST:STUDY_SUMMARY were strongly associated with significant differences in urinary metabolites ST:STUDY_SUMMARY (e.g. L-carnitine and hydroxycinnamic acid).In addition, metabolic pathway ST:STUDY_SUMMARY analyses revealed significant alterations in glycolysis/glycolysis, ST:STUDY_SUMMARY phenylalanine metabolism, and other pathways in the disease state.This study ST:STUDY_SUMMARY systematically reveals for the first time the gut microbiome and metabolome ST:STUDY_SUMMARY characteristics of healthy and diseased populations of different ethnic groups ST:STUDY_SUMMARY in Xinjiang region, which provides a new perspective for understanding the role ST:STUDY_SUMMARY of gut microbes in metabolic diseases and potential scientific basis for early ST:STUDY_SUMMARY diagnosis and personalised treatment of diseases. Future studies will further ST:STUDY_SUMMARY combine multi-omics technology and longitudinal design to comprehensively reveal ST:STUDY_SUMMARY the interactions among factors and specific mechanisms. ST:INSTITUTE Xinjiang University ST:LABORATORY Laboratory of Synthetic Biology ST:LAST_NAME Yue ST:FIRST_NAME Haitao ST:ADDRESS Yushugou Street, Shuimogou District, Urumqi City, Xinjiang Province ST:EMAIL yuehaitao@tsinghua.org.cn ST:PHONE 13639932226 #SUBJECT SU:SUBJECT_TYPE Human SU:SUBJECT_SPECIES Homo sapiens SU:TAXONOMY_ID 9606 SU:GENDER Female #SUBJECT_SAMPLE_FACTORS: SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data SUBJECT_SAMPLE_FACTORS KBFE_76 KBFE_76 Sample source:Human blood | ethnic group:Kazak RAW_FILE_NAME(RAW-FILE-NAME)=KBFE_76.raw; region=Changji; age=40-59; BMI=33.33 SUBJECT_SAMPLE_FACTORS KBFV_97 KBFV_97 Sample source:Human blood | ethnic group:Kazak RAW_FILE_NAME(RAW-FILE-NAME)=KBFV_97.raw; region=Changji; age=40-59; BMI=23.88 SUBJECT_SAMPLE_FACTORS KBFV_103 KBFV_103 Sample source:Human blood | ethnic group:Kazak RAW_FILE_NAME(RAW-FILE-NAME)=KBFV_103.raw; region=Changji; age=40-59; BMI=24.34 SUBJECT_SAMPLE_FACTORS KBFV_204 KBFV_204 Sample source:Human blood | ethnic group:Kazak RAW_FILE_NAME(RAW-FILE-NAME)=KBFV_204.raw; region=Changji; age=40-59; BMI=25.71 SUBJECT_SAMPLE_FACTORS KBFV_285 KBFV_285 Sample source:Human blood | ethnic group:Kazak RAW_FILE_NAME(RAW-FILE-NAME)=KBFV_285.raw; region=Changji; age=60-79; BMI=28.01 SUBJECT_SAMPLE_FACTORS UQFE_28 UQFE_28 Sample source:Human blood | ethnic group:Uyghurs RAW_FILE_NAME(RAW-FILE-NAME)=UQFE_28.raw; region=Kashi; age=60-79; BMI=27.77 SUBJECT_SAMPLE_FACTORS UQFE_40 UQFE_40 Sample source:Human blood | ethnic group:Uyghurs RAW_FILE_NAME(RAW-FILE-NAME)=UQFE_40.raw; region=Kashi; age=60-79; BMI=29.38 SUBJECT_SAMPLE_FACTORS UQFV_67 UQFV_67 Sample source:Human blood | ethnic group:Uyghurs RAW_FILE_NAME(RAW-FILE-NAME)=UQFV_67.raw; region=Kashi; age=40-59; BMI=27.72 SUBJECT_SAMPLE_FACTORS UQFV_102 UQFV_102 Sample source:Human blood | ethnic group:Uyghurs RAW_FILE_NAME(RAW-FILE-NAME)=UQFV_102.raw; region=Kashi; age=40-59; BMI=21.45 SUBJECT_SAMPLE_FACTORS UQFV_194 UQFV_194 Sample source:Human blood | ethnic group:Uyghurs RAW_FILE_NAME(RAW-FILE-NAME)=UQFV_194.raw; region=Kashi; age=40-59; BMI=17.91 #COLLECTION CO:COLLECTION_SUMMARY Blood samples: Also collected before breakfast, blood is taken using a sterile CO:COLLECTION_SUMMARY needle and the blood is quickly drawn into a sterile blood collection tube. A CO:COLLECTION_SUMMARY moderate amount of blood (5-10 ml) usually needs to be drawn. Make sure the CO:COLLECTION_SUMMARY collection environment is clean. Seal the collected blood sample in a sterile CO:COLLECTION_SUMMARY container and store it in a dry freezer to ensure that the container does not CO:COLLECTION_SUMMARY leak. In order to separate the different components of the blood, the blood CO:COLLECTION_SUMMARY collection tube containing the blood sample is placed in a centrifuge and the CO:COLLECTION_SUMMARY collected blood sample is centrifuged at a speed of 1000 - 3000 rpm. CO:COLLECTION_PROTOCOL_ID KY2023060173 CO:SAMPLE_TYPE Blood (plasma) CO:STORAGE_CONDITIONS -80°C #TREATMENT TR:TREATMENT_SUMMARY No treatment. #SAMPLEPREP SP:SAMPLEPREP_SUMMARY 1. Thaw the experimental samples at 4°C, vortex the samples for 1 min after SP:SAMPLEPREP_SUMMARY thawing, and mix well. 2. Accurately pipette the appropriate amount of sample SP:SAMPLEPREP_SUMMARY into a 2 mL centrifuge tube and add 100 μL of 2-chloro-L-phenylalanine prepared SP:SAMPLEPREP_SUMMARY with 80% methanol water (4 ppm), vortex for 1 min; 3. Centrifuge at 12000 rpm at SP:SAMPLEPREP_SUMMARY 4°C for 10 min, take the supernatant and filter through a 0.22 μm membrane, SP:SAMPLEPREP_SUMMARY and add the filtrate to the detection bottle for use LC-MS assays. #CHROMATOGRAPHY CH:CHROMATOGRAPHY_SUMMARY neg:Solvent A is 0% acetonitrile / 100% water; 5 mmol/L ammonium formate; CH:CHROMATOGRAPHY_SUMMARY neg:Solvent B is 100% acetonitrile / 0% water; 0 mmol ammonium formate per CH:CHROMATOGRAPHY_SUMMARY liter; CH:CHROMATOGRAPHY_TYPE Reversed phase CH:INSTRUMENT_NAME Thermo Vanquish CH:COLUMN_NAME Waters ACQUITY UPLC HSS T3 (100 x 2.1mm,1.8um) CH:SOLVENT_A 100% water; 5mM ammonium formate CH:SOLVENT_B 100% acetonitrile CH:FLOW_GRADIENT 0 to 1 minute, 8% B; 1 to 8 minutes, B increases linearly from 8% to 98%; 8 to CH:FLOW_GRADIENT 10 minutes, 98% B; 10 to 10.1 minutes, B from 98% to 8%; 10.1 to 12 minutes, 8% CH:FLOW_GRADIENT B. CH:FLOW_RATE 0.3 mL/min CH:COLUMN_TEMPERATURE 40 ℃ CH:METHODS_FILENAME Chromatographic_experiments.pdf #ANALYSIS AN:ANALYSIS_TYPE MS AN:ANALYSIS_PROTOCOL_FILE Chromatographic_experiments.pdf #MS MS:INSTRUMENT_NAME Thermo Orbitrap Exploris 120 MS:INSTRUMENT_TYPE Orbitrap MS:MS_TYPE ESI MS:ION_MODE NEGATIVE MS:MS_COMMENTS Simultaneous MS1 and MS/MS (Full MS-ddMS2 mode, data-dependent MS/MS) MS:MS_COMMENTS acquisition was used. The parameters were as follows: sheath gas pressure, 40 MS:MS_COMMENTS arb; aux gas flow, 10 arb; spray voltage, 3.50 kV and -2.50 kV for ESI(-), MS:MS_COMMENTS respectively; capillary temperature, 325 ℃; MS1 range, m/z 100-1000; MS1 MS:MS_COMMENTS resolving power, 60000 FWHM; number of data dependant scans per cycle, 4; MS/MS MS:MS_COMMENTS resolving power, 15000FWHM; normalized collision energy, 30%; dynamic exclusion MS:MS_COMMENTS time, automatic MS:MS_RESULTS_FILE ST003811_AN006266_Results.txt UNITS:N/A Has m/z:Yes Has RT:Yes RT units:Seconds #END